Market revenue in 2023 | USD 40.7 million |
Market revenue in 2030 | USD 84.9 million |
Growth rate | 11.1% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 58.23% in 2023. Horizon Databook has segmented the Brazil deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
In addition, presence of hospitals with well established infrastructure in Brazil attracts patients from other countries for treatment of various neurological diseases. Moreover, owing to rising incidence of epilepsy & PD and lack of awareness about their treatment, various government organizations are organizing awareness programs.
For instance, in November 2017, the Brazilian Association of Epilepsy (ABE) launched a new program to increase awareness about epilepsy among children. Thus, increasing awareness coupled with rising prevalence of neurological diseases is expected to boost the adoption of deep brain stimulation devices in the country.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account